High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone.
| Image |  |
|---|---|
| Description | scientific article published on 9 April 2013 |
| Author/s |
author: Antonio Palumbo Heinz Ludwig |
| Publication date | April 9, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |